Cetuximab Induces Eme1-Mediated DNA Repair: a Novel Mechanism for Cetuximab Resistance

Overexpression of the epidermal growth factor receptor (EGFR) is observed in a large number of neoplasms. The monoclonal antibody cetuximab/Erbitux is frequently applied to treat EGFR-expressing tumors. However, the application of cetuximab alone or in combination with radio- and/or chemotherapy of...

Full description

Bibliographic Details
Main Authors: Agnieszka Weinandy, Marc D. Piroth, Anand Goswami, Kay Nolte, Bernd Sellhaus, Jose Gerardo-Nava, Michael Eble, Stefan Weinandy, Christian Cornelissen, Hans Clusmann, Bernhard Lüscher, Joachim Weis
Format: Article
Language:English
Published: Elsevier 2014-03-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558614000153